University of Valencia logo Logo Eukaryotic Gene Expression Research Group: from DNA to Proteins (EGE-DtoP) Logo del portal

Translational control in cancer. European Network (TRANSLACORE)

RANSLACORE is a network of researchers working on various aspects of protein synthesis across Europe, aiming to advance the emerging field of translational control in cancer. It is continuously growing and optimizing to reach a large, but unified European network gathering, consisting of researchers, clinicians and teachers from universities, hospital, research institutes, public institutions, biotechnology and pharmaceutical companies, along with representatives from patient advocacy groups and policy makers from governmental institutions.
Acronym

Translacore

Reference code

CA21154

Description

The ambition of TRANSLACORE is map and foster the European research expertise on RNA biology and protein synthesis in order to accelerate the robust transfer of academic findings into medical applications dedicated to improve the health and quality of life of people afflicted by cancer.

The TRANSLACORE has the potential to provide innovative strategies and therapeutic avenues improving the management and health outcomes for patients with cancer. Advancing the frontiers of human knowledge in translational control is likely to contribute to uncovering the cancer's Achille's heel and to accelerate development of therapeutic approaches allowing a precision modulation of translational machinery in cancer.

To fulfil this purpose, the following objectives are our focus:

  • Promoting multiple cross-disciplinary research partnerships,

  • Promoting access to state-of-the-art technologies and harmonization experimental procedures,
  • Closing the gap between basic research and clinical applications,
  • Educating the current and next generation of scientists,
  • Facilitating access to EU funding.

The network consists of five working groups focused on overlapping topics:

  • Scientific and technological developments and harmonization procedures.
  • Clinical samples/patient cohort coordination and ethics.
  • Bioinformatics and big data management.
  • Dissemination, sharing of knowledge and know-how, to the wider society.
  • Education.

 

Developers of the project
Eukaryotic gene expression: from DNA to protein (EGE-DtoP)
Keywords

cancer, knowledge transfer, molecular biology, transcription, transplantation

Non-UV principal researchers

Alexandre David , Fátima Gebauer et. al.

Participating researchers:
  • Alepuz Martinez, Elia Paula
  • PDI-Catedratic/a d'Universitat
View details
Start date
2022 October
End date
2026 October
Funding agencies:

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. (www.cost.eu).

Funding networking activities

European Cooperation in Science and Technology (COST) creates open spaces where people and ideas can grow.

COST funds interdisciplinary research networks called COST Actions. These Actions bring together researchers, innovators and other professionals including industry specialists, who are based in Europe and beyond, to collaborate on research topics for a period of 4 years.

  • The budget: an estimated €125,000 is made available for a COST Action in its first year and an average of €150,000 per year for the other 3 years.

Results

  • Meetings.
  • Data platform.
  • Summer School.
  • Training School.
  • Publications.
  • Galleries.

Visit the web project to more information 

Project type
  • EU - Horizon Europe (HE): European Cooperation in Science and Technology (COST)